Evaxion CEO Departs; CFO and Interim CEO Appointed

Dow Jones
Jul 01
 

By Denny Jacob

 

Evaxion said Chief Executive Christian Kanstrup has stepped down and that a search for its next leader is under way.

The clinical-stage tech-bio company said Chief Scientific Officer Birgitte Rønø was appointed interim CEO. Rønø has been with Evaxion since 2017 and joined its executive management in 2021.

Additionally, Thomas Schmidt was named permanent chief financial officer after joining the company in November as interim CFO.

 

Write to Denny Jacob at denny.jacob@wsj.com

 

(END) Dow Jones Newswires

July 01, 2025 08:46 ET (12:46 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10